Unlocking Q4 Potential of Walgreens (WBA): Exploring Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Walgreens (WBA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during th...
Walgreens names Optum's Jason Stenta as chief commercial officer
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Walgreens Boots Allianc...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 18, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors ...
Walgreens: So Bad It's Good Heading Into Earnings (Rating Upgrade)
Walgreens (WBA) faces a challenging outlook with weak profit forecasts and negative EPS revisions, but technical signals suggest a potential upside, prompting a buy rating. Despite bearish trends a...
Walgreens stock is cheap and oversold: is it a value trap?
Walgreens Boots Alliance (WBA) has become a fallen angel, costing investors billions of dollars in the past few years. Its stock has imploded, falling from $69 in 2014 to $9 today, meaning that a $...
5 Things You Need to Know If You Buy Walgreens Today
Walgreens stock is taking a hit, in part, because of prescription reimbursement pressures from insurers. Walgreens also made a poor acquisition that continues to weigh on its results.
WBA Stock Dips 5% Post Fed Rate Cut: Should You Sell Walgreens Boots?
WBA is currently facing challenges within its U.S. Retail Pharmacy segment due to an unfavorable consumer environment and adverse pharmacy industry trends.
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Walgreens Boots Alliance, Inc. (NASDAQ: WBA); Investors with Loss...
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) (“Walgreens” or the “Company”) common sto...
Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of Its Executives
BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Northern Di...
WALGREENS ALERT: Bragar Eagel & Squire, P.C. is Investigating Walgreens Boots Alliance, Inc. on Behalf of Long-Term Stockholders and Encourages Inv...
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Walgreens Boots Alliance, In...
Where Will Walgreens Boots Alliance Be in 3 Years?
Walgreens Boots Alliance does not have big plans for the next three years. It may need to undergo more painful cost cuts, downsizing, and deleveraging.
Is Walgreens Boots Alliance Stock a Buy?
Walgreens Boots Alliance may be an interesting turnaround or deep value play. It's heavily indebted and experiencing difficulty growing.
Walgreens paying $106.8 million to settle US charges over prescription billing fraud
Walgreens Boots Alliance agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Fri...
Walgreens agrees to pay $106.8 mln to settle US charges over prescription billing
Walgreens Boots Alliance agreed to pay $106.8 million to settle charges it billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday.
Walgreens Boots Alliance, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 10, 2024 Deadline to file Lead Plai...
Investors can contact the law firm at no cost to learn more about recovering their losses
Related Companies